Laura Shawver hits the ground running, scouting new investors for tiny Synthorx
Synthorx doesn’t make the news a lot. But when it does, it makes sure people pay attention.
The synthetic biology startup came out with two big announcements this week: Laura Shawver is taking its helm as CEO, president and director; scientific founder Floyd Romesberg has published a paper in Nature discussing how a semi-synthetic organism can translate DNA with two additional bases (X and Y) into novel proteins.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.